FindTrial
Sign In

Clinical Trial to study effect of Vitamin D3 levels in hair loss of more than 6 months duration

To Establish The Association of Vitamin D3 Levels With The Duration of Chronic Telogen Effluvium in Females - A Hospital based Case Control Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057924
Enrollment
80
Registered
2023-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

Intervention1: Serum vitamin d3 level: blood test in chronic telogen effluvium done once on patients first visit Control Intervention1: Serum vitamin d3 level: Blood test in healthy controls done once

Sponsors

Amrit Malik
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients giving written informed consent for the study 2. All female patients coming to dermatology OPD of age 18 and above diagnosed with Chronic Telogen Effluvium who have not taken any treatment or supplements in the last 4 weeks 3. Healthy females will be taken as controls and matched with age

Exclusion criteria

Exclusion criteria: 1. Patients with signs other types of alopecia 2. Pregnant and lactating females 3. Women having any malignancy, systemic or local scalp disease 4. Female with previous history of multivitamin supplementation or taking drugs that may alter Vitamin D3 in the last 4 weeks

Design outcomes

Primary

MeasureTime frame
1.level of vitamin d3 correlated with duration of symptoms in chronic telogen effluviumTimepoint: 12 months—

Secondary

MeasureTime frame
1. to find any associated dermatoses in patients with low vitamin d3Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr. Amrit Malik

Mahatma Gandhi Medical College and Hospital

m.nijhawan12@gmail.com9314503401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026